Randomized Controlled Trial Comparing Intracoronary Administration of Adenosine or Sodium Nitroprusside to Control for Attenuation of Microvascular Obstruction During Primary Percutaneous Coronary Intervention
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Adenosine; Sodium nitroprusside
- Indications Myocardial infarction
- Focus Biomarker; Therapeutic Use
- Acronyms MVO
- 16 Jun 2015 Biomarkers information updated
- 16 Jan 2014 Accrual to date is 71% according to United Kingdom Clinical Research Network.
- 04 Dec 2013 Accrual to date is 69% according to United Kingdom Clinical Research Network.